Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
»
Pfizer's academic-partnered R&D unit is scrapped as part of cost-cutting measures
Fierce Biotech
Wed, 04/17/24 - 11:20 am
Pfizer
R&D
Roche
AI-Driven Drug Discovery: Transforming the Landscape of Pharmaceutical Research
Drug Patent Watch
Wed, 04/17/24 - 11:16 am
China
drug discovery
artificial intelligence
QT imaging’s breast imaging system proves as effective as mammography
Clinical Trials Arena
Wed, 04/17/24 - 11:15 am
Medtech
QT Imaging
Breast Acoustic
breast cancer
mammography
Traditional gene therapies are uber-niche. Ocugen hopes to change that.
Pharma Voice
Wed, 04/17/24 - 11:14 am
gene therapy
Ocugen
Luxturna
3 patent expirations in 2024 and how companies are pivoting
Pharma Voice
Wed, 04/17/24 - 11:13 am
patents
patent cliff
Bayer
J&J
Xarelto
Novo Nordisk
Victoza
Otsuka
Lundbeck
Abilify
Lilly's Prevail walks away from gene editing collab with Precision
Fierce Biotech
Wed, 04/17/24 - 11:11 am
Eli Lilly
Prevail Therapeutics
gene editing
Precision Biosciences
Abbott beats Wall Street expectations with med device sales, raises outlook
Medical Marketing and Media
Wed, 04/17/24 - 11:10 am
Medtech
earnings
Abbott Labs
Biotech naming trends bypass 'buzzwords and business speak' to build whimsical, memorable brands
Fierce Biotech
Tue, 04/16/24 - 10:13 pm
biotech
branding
US to see surge in new obesity drug launches in next five years
Biopharma Reporter
Tue, 04/16/24 - 10:11 pm
obesity
drug launches
weight loss
Takeda inks sweet $1.2B+ deal with Kumquat for immuno-oncology program
Fierce Biotech
Tue, 04/16/24 - 10:10 pm
Takeda
Kumquat Biosciences
biobucks
immuno-oncology
UnitedHealth cyberattack: Things won't be back to normal until 2025
Axios
Tue, 04/16/24 - 10:09 pm
Unitedhealth Group
cyberattack
cybersecurity
earnings
‘We think in decades’: J&J’s $30B spending spree may not be over
Medtech Dive
Tue, 04/16/24 - 10:07 pm
JNJ
Medtech
M&A
Abiomed
Laminar
Shockwave Medical
Arrowhead's plozasiran could reach $700M-plus in sales by 2032, meet major unmet need in dyslipidemia: GlobalData
Fierce Pharma
Tue, 04/16/24 - 10:05 pm
Arrowhead Pharmaceuticals
clinical trials
RNAi
plozasiran
dyslipidemia
Regeneron to defend against DOJ complaint on drug-price manipulation
Yahoo/Reuters
Tue, 04/16/24 - 10:02 pm
Regeneron
DOJ
drug pricing
Eylea
April 16 2024 - J&J narrowly misses Q1 revenue on lower-than-expected Stelara sales
Tue, 04/16/24 - 11:22 am
J&J narrowly misses Q1 revenue on lower-than-expected Stelara sales
BioSpace
Tue, 04/16/24 - 11:19 am
JNJ
earnings
Ukraine was pharma’s ‘darling’ of clinical trials. As war drags on, will the industry come back?
Pharma Voice
Tue, 04/16/24 - 11:17 am
Ukraine
clinical trials
Why are US pharmacy benefit managers under fire?
Reuters
Tue, 04/16/24 - 11:14 am
PBMs
congress
Cigna
Humana
CVS Health
Intra-Cellular Launches 26% To Record High, Breaking Out After Depression Drug Scores Big
Investors Business Daily
Tue, 04/16/24 - 11:13 am
Intra-Cellular Therapies
Caplyta
clinical trials
major depressive disorder
Biotech landlord Alexandria on research clusters and the sector’s recovery
Biopharma Dive
Tue, 04/16/24 - 11:09 am
Alexandria
biotech
biotech hubs
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »